Meningitis B Vaccine for Teens Recommended by UK Advisers 2026

The meningitis B vaccine should be offered to all teenagers across the UK on the NHS, a government committee has recommended following a series of fatal outbreaks. The Joint Committee on Vaccination and Immunisation (JCVI) advises that young people become eligible for the menB vaccine at age 15, with catch-up programs for those who missed it.

Why the Meningitis B Vaccine Recommendation Matters

This recommendation comes after several meningitis outbreaks across the UK, resulting in dozens of confirmed cases and multiple deaths. In March, a major outbreak in Kent linked to a Canterbury nightclub killed two people and left over a dozen needing hospital treatment. A similar outbreak in Berkshire in May led to the death of a school student.

Key Details of the JCVI Proposal

The committee specifically recommends a booster jab for those aged around 15 who had the menB jab as an infant. The first cohort to benefit will be those turning 15 in 2030. Children who missed the jab as a baby will be offered two doses.

Expert Commentary

Prof Wei Shen Lim, chair of the JCVI, stated: "Invasive meningococcal disease is a rare but very serious illness, which can have a devastating impact on lives. JCVI has worked closely with meningitis charities and would like to thank all those who responded, including on behalf of loved ones who sadly died or had life-changing complications."

What This Means for Parents and Teens

As a precaution, a one-off vaccination campaign has already been launched across the UK this summer for around a million young people attending university or other further residential education in the autumn. This proactive measure aims to prevent further tragedies.

Key Takeaways

• The meningitis B vaccine is recommended for all teenagers at age 15.
• Catch-up programs will cover those who missed infant doses.
• Recent outbreaks in Kent and Berkshire underscore the urgency.
• A one-off campaign targets university-bound students this summer.

FAQ